Cancer Institute A national cancer institute
designated cancer center

Sylvia K. Plevritis, PhD

Publication Details

  • Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development.

    Inlay MA, Bhattacharya D, Sahoo D, Serwold T, Seita J, Karsunky H, Plevritis SK, Dill DL, Weissman IL. Genes Dev. 2009; 23 (20): 2376-81

    Common lymphoid progenitors (CLPs) clonally produce both B- and T-cell lineages, but have little myeloid potential in vivo. However, some studies claim that the upstream lymphoid-primed multipotent progenitor (LMPP) is the thymic seeding population, and suggest that CLPs are primarily B-cell-restricted. To identify surface proteins that distinguish functional CLPs from B-cell progenitors, we used a new computational method of Mining Developmentally Regulated Genes (MiDReG). We identified Ly6d, which divides CLPs into two distinct populations: one that retains full in vivo lymphoid potential and produces more thymocytes at early timepoints than LMPP, and another that behaves essentially as a B-cell progenitor.

    PubMedID: 19833765

Stanford Medicine Resources:

Footer Links: